BIO.NRW COVID-19
Information and
Contact Platform
Current information in connection with the COVID-19 pandemic
At this point BIO.NRW offers all companies and scientists in NRW a platform with actual informations in connection with the COVID-19 pandemic. This includes support programs and funding from the state, the federal government and the EU as well as relevant news from companies and science.
In addition, we also offer you the possibility of individual cooperation and contact requests: If you have offers for your (product) development regarding COVID-19 in the fields of diagnostics, therapy, prevention, clinical studies or in a broader sense to medical technology solutions and/or are looking for partners, please feel free to contact us via email at bio.nrw@bio.nrw.de.
We will publish your offers and/or requests in this area. In case you do not wish to publish your information, you are nevertheless welcome to contact the office so that we can support you while maintaining confidentiality.
Click here for the contact form.
Corona platform of the EU with information on funding opportunities related with Covid-19
Weiterlesen …
Übersicht zu COVID-19 assoziierter (und allgemeiner) Förderung, Finanzierung, Information
Weiterlesen …
COVID-19 News
Phase II Clinical Trial of the COVID-19 Vaccine of Janssen Authorised in Germany
The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, has approved the Phase II clinical trial of the SARS-CoV-2 vaccine candidate Ad26 COV2.S by Janssen against COVID-19 in Germany. The phase...
QIAGEN to launch rapid portable test that can detect active infections of SARS-CoV-2 in less than 15 min
Access Anti-SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, is easy to use and provides accurate results in less than 15 minutes…
...